NVS logo

Novartis AG (NVS) Interest Expense

Annual Interest Expense

$1.01 B
+$151.00 M+17.66%

December 31, 2024

Summary

Performance

1-Year Change

+17.66%

3-Year Change

+27.83%

5-Year Change

+18.35%

15-Year Change

+34.13%

NVS Interest Expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

98.5%
NVS annual interest expense is higher than 98.5% of companies in Healthcare sector

High & Low

All-time High

$1.01 B
NVS annual interest expense is currently at an all-time high

3-Year Low

$787.00 M
NVS annual interest expense is currently +27.83% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
NVS previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
NVS next annual earnings announcement has not yet been scheduled

OtherNVSexpensesmetrics:

Annual Total Expenses

$37.18 B
NVS annual total expenses is $37.18 billion

Annual Operating Expenses

$24.35 B
NVS annual total operating expenses is $24.35 billion

Annual Cost Of Goods Sold

$12.83 B
NVS annual cost of goods sold is $12.83 billion

Annual Income Tax

$1.70 B
NVS annual income tax is $1.70 billion

Quarterly Interest Expense

$275.00 M
+$11.00 M+4.17%

December 31, 2024

Summary

Performance

3-Month Change

+4.17%

1-Year Change

+26.73%

3-Year Change

+23.87%

5-Year Change

+23.87%

NVS Quarterly Interest Expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

98.61%
NVS quarterly interest expense is higher than 98.61% of companies in Healthcare sector

High & Low

All-time High

$275.00 M
NVS quarterly interest expense is currently at an all-time high

3-Year Low

$182.00 M
NVS quarterly interest expense is currently +51.10% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
NVS previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

Apr 23, 2025
NVS next earnings announcement is scheduled for Apr 23, 2025

OtherNVSexpensesmetrics:

Quarterly Total Expenses

$10.03 B
NVS quarterly total expenses is $10.03 billion

Quarterly Operating Expenses

$6.70 B
NVS quarterly total operating expenses is $6.70 billion

Quarterly Cost Of Goods Sold

$3.32 B
NVS quarterly cost of goods sold is $3.32 billion

Quarterly Income Tax

$465.00 M
NVS quarterly income tax is $465.00 million

TTM Interest Expense

$1.01 B
+$58.00 M+6.12%

December 31, 2024

Summary

Performance

3-Month Change

+6.12%

1-Year Change

+17.66%

3-Year Change

+19.05%

5-Year Change

+19.05%

NVS TTM Interest Expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

98.61%
NVS TTM interest expense is higher than 98.61% of companies in Healthcare sector

High & Low

All-time High

$1.01 B
NVS TTM interest expense is currently at an all-time high

3-Year Low

$786.00 M
NVS TTM interest expense is currently +27.99% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
NVS previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

Apr 23, 2025
NVS next earnings announcement is scheduled for Apr 23, 2025

OtherNVSexpensesmetrics:

Annual Total Expenses

$37.18 B
NVS annual total expenses is $37.18 billion

Annual Operating Expenses

$24.35 B
NVS annual total operating expenses is $24.35 billion

TTM Cost Of Goods Sold

$12.83 B
NVS TTM cost of goods sold is $12.83 billion

TTM Income Tax

$1.70 B
NVS TTM income tax is $1.70 billion

Interest Expense Formula

Interest Expense = Carrying Value of Debt X Effective Interest Rate

NVS Interest Expense Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+17.7%+26.7%+17.7%
3 y3 years+27.8%+23.9%+19.1%
5 y5 years+18.4%+23.9%+19.1%

NVS Interest Expense Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+27.8%at high+51.1%at high+28.0%
5 y5-yearat high+27.8%at high+51.1%at high+28.0%
alltimeall timeat high+418.6%at high+350.8%at high+1549.2%

Novartis AG Interest Expense History

DateAnnualQuarterlyTTM
Dec 2024
$1.01 B(+17.7%)
$275.00 M(+4.2%)
$1.01 B(+6.1%)
Sep 2024
-
$264.00 M(+7.3%)
$948.00 M(+4.6%)
Jun 2024
-
$246.00 M(+11.3%)
$906.00 M(+3.4%)
Mar 2024
-
$221.00 M(+1.8%)
$876.00 M(+2.5%)
Dec 2023
$855.00 M(+6.9%)
$217.00 M(-2.3%)
$855.00 M(+1.2%)
Sep 2023
-
$222.00 M(+2.8%)
$845.00 M(+1.9%)
Jun 2023
-
$216.00 M(+8.0%)
$829.00 M(+1.7%)
Mar 2023
-
$200.00 M(-3.4%)
$815.00 M(-0.1%)
Dec 2022
$800.00 M(+1.7%)
$207.00 M(+0.5%)
$816.00 M(+3.2%)
Sep 2022
-
$206.00 M(+2.0%)
$791.00 M(+0.5%)
Jun 2022
-
$202.00 M(+0.5%)
$787.00 M(+0.1%)
Mar 2022
-
$201.00 M(+10.4%)
$786.00 M(-0.1%)
Dec 2021
$787.00 M(-9.4%)
$182.00 M(-9.9%)
$787.00 M(-2.4%)
Sep 2021
-
$202.00 M(+0.5%)
$806.00 M(-0.9%)
Jun 2021
-
$201.00 M(-0.5%)
$813.00 M(-2.3%)
Mar 2021
-
$202.00 M(+0.5%)
$832.00 M(-4.3%)
Dec 2020
$869.00 M(+2.2%)
$201.00 M(-3.8%)
$869.00 M(-0.2%)
Sep 2020
-
$209.00 M(-5.0%)
$871.00 M(-0.8%)
Jun 2020
-
$220.00 M(-7.9%)
$878.00 M(+1.7%)
Mar 2020
-
$239.00 M(+17.7%)
$863.00 M(+1.5%)
Dec 2019
$850.00 M(-8.8%)
$203.00 M(-6.0%)
$850.00 M(-5.0%)
Sep 2019
-
$216.00 M(+5.4%)
$895.00 M(-1.4%)
Jun 2019
-
$205.00 M(-9.3%)
$908.00 M(-3.4%)
Mar 2019
-
$226.00 M(-8.9%)
$940.00 M(+0.9%)
Dec 2018
$932.00 M(+24.3%)
$248.00 M(+8.3%)
$932.00 M(+7.7%)
Sep 2018
-
$229.00 M(-3.4%)
$865.00 M(+3.8%)
Jun 2018
-
$237.00 M(+8.7%)
$833.00 M(+5.7%)
Mar 2018
-
$218.00 M(+20.4%)
$788.00 M(+5.1%)
Dec 2017
$750.00 M(+6.1%)
$181.00 M(-8.1%)
$750.00 M(+1.8%)
Sep 2017
-
$197.00 M(+2.6%)
$737.00 M(+3.2%)
Jun 2017
-
$192.00 M(+6.7%)
$714.00 M(+1.7%)
Mar 2017
-
$180.00 M(+7.1%)
$702.00 M(-0.7%)
Dec 2016
$707.00 M(+7.9%)
$168.00 M(-3.4%)
$707.00 M(+1.4%)
Sep 2016
-
$174.00 M(-3.3%)
$697.00 M(+3.0%)
Jun 2016
-
$180.00 M(-2.7%)
$677.00 M(+2.4%)
Mar 2016
-
$185.00 M(+17.1%)
$661.00 M(+0.9%)
Dec 2015
$655.00 M
$158.00 M(+2.6%)
$655.00 M(-4.4%)
DateAnnualQuarterlyTTM
Sep 2015
-
$154.00 M(-6.1%)
$685.00 M(-3.9%)
Jun 2015
-
$164.00 M(-8.4%)
$713.00 M(-0.3%)
Mar 2015
-
$179.00 M(-4.8%)
$715.00 M(+1.6%)
Dec 2014
$704.00 M(+3.1%)
$188.00 M(+3.3%)
$704.00 M(+3.7%)
Sep 2014
-
$182.00 M(+9.6%)
$679.00 M(+1.8%)
Jun 2014
-
$166.00 M(-1.2%)
$667.00 M(-1.3%)
Mar 2014
-
$168.00 M(+3.1%)
$676.00 M(-1.0%)
Dec 2013
$683.00 M(-5.7%)
$163.00 M(-4.1%)
$683.00 M(-5.0%)
Sep 2013
-
$170.00 M(-2.9%)
$719.00 M(-1.1%)
Jun 2013
-
$175.00 M(0.0%)
$727.00 M(-1.1%)
Mar 2013
-
$175.00 M(-12.1%)
$735.00 M(+1.5%)
Dec 2012
$724.00 M(-3.6%)
$199.00 M(+11.8%)
$724.00 M(+3.6%)
Sep 2012
-
$178.00 M(-2.7%)
$699.00 M(-2.8%)
Jun 2012
-
$183.00 M(+11.6%)
$719.00 M(-1.0%)
Mar 2012
-
$164.00 M(-5.7%)
$726.00 M(-3.3%)
Dec 2011
$751.00 M(+8.5%)
$174.00 M(-12.1%)
$751.00 M(-2.8%)
Sep 2011
-
$198.00 M(+4.2%)
$773.00 M(+1.3%)
Jun 2011
-
$190.00 M(+0.5%)
$763.00 M(+2.0%)
Mar 2011
-
$189.00 M(-3.6%)
$748.00 M(+8.1%)
Dec 2010
$692.00 M(+25.6%)
$196.00 M(+4.3%)
$692.00 M(+6.1%)
Sep 2010
-
$188.00 M(+7.4%)
$652.00 M(+2.4%)
Jun 2010
-
$175.00 M(+31.6%)
$637.00 M(+6.5%)
Mar 2010
-
$133.00 M(-14.7%)
$598.00 M(+8.5%)
Dec 2009
$551.00 M(+90.0%)
$156.00 M(-9.8%)
$551.00 M(+17.0%)
Sep 2009
-
$173.00 M(+27.2%)
$471.00 M(+19.5%)
Jun 2009
-
$136.00 M(+58.1%)
$394.00 M(+23.5%)
Mar 2009
-
$86.00 M(+13.2%)
$319.00 M(+36.9%)
Dec 2008
$290.00 M(+22.4%)
$76.00 M(-20.8%)
$233.00 M(+48.4%)
Sep 2008
-
$96.00 M(+57.4%)
$157.00 M(+157.4%)
Jun 2008
-
$61.00 M
$61.00 M
Dec 2007
$237.00 M(-10.9%)
-
-
Dec 2006
$266.00 M(-9.5%)
-
-
Dec 2005
$294.00 M(+12.6%)
-
-
Dec 2004
$261.00 M(+7.4%)
-
-
Dec 2003
$243.00 M(+25.3%)
-
-
Dec 2002
$194.00 M(-11.0%)
-
-
Dec 2001
$218.00 M
-
-

FAQ

  • What is Novartis AG annual interest expense?
  • What is the all time high annual interest expense for Novartis AG?
  • What is Novartis AG annual interest expense year-on-year change?
  • What is Novartis AG quarterly interest expense?
  • What is the all time high quarterly interest expense for Novartis AG?
  • What is Novartis AG quarterly interest expense year-on-year change?
  • What is Novartis AG TTM interest expense?
  • What is the all time high TTM interest expense for Novartis AG?
  • What is Novartis AG TTM interest expense year-on-year change?

What is Novartis AG annual interest expense?

The current annual interest expense of NVS is $1.01 B

What is the all time high annual interest expense for Novartis AG?

Novartis AG all-time high annual interest expense is $1.01 B

What is Novartis AG annual interest expense year-on-year change?

Over the past year, NVS annual interest expense has changed by +$151.00 M (+17.66%)

What is Novartis AG quarterly interest expense?

The current quarterly interest expense of NVS is $275.00 M

What is the all time high quarterly interest expense for Novartis AG?

Novartis AG all-time high quarterly interest expense is $275.00 M

What is Novartis AG quarterly interest expense year-on-year change?

Over the past year, NVS quarterly interest expense has changed by +$58.00 M (+26.73%)

What is Novartis AG TTM interest expense?

The current TTM interest expense of NVS is $1.01 B

What is the all time high TTM interest expense for Novartis AG?

Novartis AG all-time high TTM interest expense is $1.01 B

What is Novartis AG TTM interest expense year-on-year change?

Over the past year, NVS TTM interest expense has changed by +$151.00 M (+17.66%)